Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Dinh

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The AAPS Journal|November 4, 2025
Investigating Sulfotransferase Mediated Drug Interactions of Ethinylestradiol using a Physiologically Based Pharmacokinetic ModelHarry P Moore, Kuan-Fu Chen, Aki T Heikkinen, et al.
Frontiers in Pharmacology|June 5, 2026
Developmental age and clinical illness drive <i>in vivo</i> variability of CYP1A2 ontogeny and caffeine metabolism in preterm neonatesMichelle Chenghuazou Wang, Victoria A Sealey, Mehzabin Rahman, et al.
Clinical Pharmacology and Therapeutics|August 1, 2023
Impact of CYP2C:TG Haplotype on CYP2C19 Substrates Clearance In Vivo, Protein Content, and In Vitro ActivityPablo Zubiaur, Paula Soria-Chacartegui, Erin C Boone, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The AAPS Journal|November 4, 2025
Investigating Sulfotransferase Mediated Drug Interactions of Ethinylestradiol using a Physiologically Based Pharmacokinetic ModelHarry P Moore, Kuan-Fu Chen, Aki T Heikkinen, et al.
Frontiers in Pharmacology|June 5, 2026
Developmental age and clinical illness drive <i>in vivo</i> variability of CYP1A2 ontogeny and caffeine metabolism in preterm neonatesMichelle Chenghuazou Wang, Victoria A Sealey, Mehzabin Rahman, et al.
Clinical Pharmacology and Therapeutics|August 1, 2023
Impact of CYP2C:TG Haplotype on CYP2C19 Substrates Clearance In Vivo, Protein Content, and In Vitro ActivityPablo Zubiaur, Paula Soria-Chacartegui, Erin C Boone, et al.
Pageof 2